Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Yongjie Xie"'
Autor:
Liangliang Wu, Yongjie Xie, Bo Ni, Peng Jin, Bin Li, Mingzhi Cai, Baogui Wang, Chengyan Wu, Yuexiang Liang, Xiaona Wang
Publikováno v:
iScience, Vol 27, Iss 3, Pp 109045- (2024)
Summary: Splenectomy often accompanies distal pancreatectomy for pancreatic cancer. However, debates persist on splenic function loss impact. Prior studies in mice revealed splenectomy promotes pancreatic cancer growth by altering CD4/Foxp3 and CD8/F
Externí odkaz:
https://doaj.org/article/26249e1c35ce4b1e8377d24cce3ad9b0
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-22 (2023)
Abstract Background Triple-negative breast cancer (TNBC) is a subtype of breast cancer with limited treatment options and poor prognosis. This study aimed to identify potential therapeutic targets based on the expression profiles of differentially ex
Externí odkaz:
https://doaj.org/article/ef26b89ecf9747c6a675992f218f99cf
Autor:
Chunhua She, Chao Wu, Weihua Guo, Yongjie Xie, Shouyi Li, Weishuai Liu, Chao Xu, Hui Li, Pei Cao, Yanfang Yang, Xiuchao Wang, Antao Chang, Yukuan Feng, Jihui Hao
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-22 (2023)
Abstract Background Gemcitabine (GEM)-based chemotherapy is the first-line option for pancreatic ductal adenocarcinoma (PDAC). However, the development of drug resistance limits its efficacy, and the specific mechanisms remain largely unknown. RUNX1,
Externí odkaz:
https://doaj.org/article/35cb9655f284424ab326102f407ef4cd
Publikováno v:
Discover Oncology, Vol 14, Iss 1, Pp 1-19 (2023)
Abstract Background PDAC is a highly malignant and immune-suppressive tumor, posing great challenges to therapy. Methods In this study, we utilized multi-center RNA sequencing and non-negative matrix factorization clustering (NMF) to identify a group
Externí odkaz:
https://doaj.org/article/97e83a4c87614538a15ca63577139597
Autor:
Tianxing Zhou, Yongjie Xie, Xupeng Hou, Weiwei Bai, Xueyang Li, Ziyun Liu, Quan Man, Jingyan Sun, Danqi Fu, Jingrui Yan, Zhaoyu Zhang, Yifei Wang, Hongwei Wang, Wenna Jiang, Song Gao, Tiansuo Zhao, Antao Chang, Xiuchao Wang, Hongxia Sun, Xiufeng Zhang, Shengyu Yang, Chongbiao Huang, Jihui Hao, Jing Liu
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-27 (2023)
Abstract Background Chemoresistance is the main reason for the poor prognosis of pancreatic ductal adenocarcinoma (PDAC). Thus, there is an urgent need to screen out new targets and compounds to reverse chemotherapeutic resistance. Methods We establi
Externí odkaz:
https://doaj.org/article/e32ae4b592a7470e8dd8678ad54192c9
Autor:
Tianxing Zhou, Quan Man, Xueyang Li, Yongjie Xie, Xupeng Hou, Hailong Wang, Jingrui Yan, Xueqing Wei, Weiwei Bai, Ziyun Liu, Jing Liu, Jihui Hao
Publikováno v:
Cancer Biology & Medicine, Vol 20, Iss 3, Pp 196-217 (2023)
Objective: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy. CD8+ T cells, cancer stem cells (CSCs), and tumor budding (TB) have been significantly correlated with the outcome of patients with PDAC, but the correlations have been i
Externí odkaz:
https://doaj.org/article/d6a9e7f1a8244667bb00cdc100d2c6c3
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Lung adenocarcinoma is a common cause of mortality in patients with cancer. Recent studies have indicated that copper-related cell death may not occur in the same way as previously described. Long non-coding RNAs (lncRNAs) play a key ro
Externí odkaz:
https://doaj.org/article/c87a76cc8fcb4676ba9136941c9307cf
Autor:
Yongjie Xie, Xiaoran Feng, Youqun Gao, Xiaojiang Zhan, Fenfen Peng, Qian Zhou, Xianfeng Wu, Xiaoyang Wang, Na Tian, Qingdong Xu, Ning Su, Xingming Tang, Jianbo Liang, Jiao Li, Yueqiang Wen
Publikováno v:
Renal Failure, Vol 46, Iss 1 (2024)
Objective Malnutrition and inflammation are associated with mortality in peritoneal dialysis (PD) patients. Serum albumin and non-high-density lipoprotein cholesterol (non-HDL-C) are independently associated with mortality in PD patients. Combining a
Externí odkaz:
https://doaj.org/article/722a214fd2f44de39a81686f762f1967
Autor:
Yongjie Xie, Yang Liu, Jinsheng Ding, Guangming Li, Bo Ni, Huifang Pang, Xin Hu, Liangliang Wu
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignant tumors worldwide and has poor prognosis. DEAD box proteins31 (DDX31) participate in cellular processes involving RNA secondary structure changes. However, the funct
Externí odkaz:
https://doaj.org/article/0a5e12ddd65e4178aa62d7738f7c6ae3
Autor:
Chunlei Shi, Yongjie Xie, Xueyang Li, Guangming Li, Weishuai Liu, Wenju Pei, Jing Liu, Xiaozhou Yu, Tong Liu
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2022)
Background: Colon adenocarcinoma (COAD) is one of the most prevalent cancers worldwide and has become a leading cause of cancer death. Although many potential biomarkers of COAD have been screened with the bioinformatics method, it is necessary to ex
Externí odkaz:
https://doaj.org/article/b03f806a6b714dc380b70144fae70080